FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

36420111000001101: Azithromycin 500mg tablets (Crescent Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Dec 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111363701000001115 Azithromycin 500mg tablets (Crescent Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111363801000001112 Azithromycin 500mg tablets (Crescent Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Is a Azithromycin 500mg tablets false Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Is a Azithromycin 500mg tablets true Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Is a Product containing precisely azithromycin dihydrate 500 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has basis of strength substance Azithromycin dihydrate true Inferred relationship Existential restriction modifier 1
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has presentation strength numerator value 500 false Inferred relationship Existential restriction modifier 1
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has precise active ingredient Azithromycin dihydrate true Inferred relationship Existential restriction modifier 1
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has specific active ingredient Azithromycin true Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Azithromycin 500mg tablets (Crescent Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Azithromycin 500mg tablets (Crescent Pharma Ltd) 3 tablet Has AMP True Azithromycin 500mg tablets (Crescent Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start